3,388
Views
148
CrossRef citations to date
0
Altmetric
Papers

Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review)

, &
Pages 353-363 | Received 14 May 2010, Accepted 08 Aug 2010, Published online: 13 Oct 2010

Figures & data

Figure 1. Illustration of tumour blood vessel fenestration due to the tumour growth and inflammatory condition in this tissue. The liposomes circulate in the blood and extravasate into the extracellular space through pores between the endothelial cells lining the blood vessel. Here the liposomes can encounter secreted enzymes such as sPLA2 or MMPs that then hydrolyze membrane moieties and induce drug release.

Figure 1. Illustration of tumour blood vessel fenestration due to the tumour growth and inflammatory condition in this tissue. The liposomes circulate in the blood and extravasate into the extracellular space through pores between the endothelial cells lining the blood vessel. Here the liposomes can encounter secreted enzymes such as sPLA2 or MMPs that then hydrolyze membrane moieties and induce drug release.

Figure 2. Illustration of how enzymes can induce a morphological change in the liposome membranes giving drug release, or induce transfection with siRNA or DNA plasmid. As an example PLA2 induces a transition to either micelle or a hexagonal phase due to the formation of lysolipids, whereas MMP will reduce headgroup size and induce a transition to an inverted micelle or the inverted hexagonal phase.

Figure 2. Illustration of how enzymes can induce a morphological change in the liposome membranes giving drug release, or induce transfection with siRNA or DNA plasmid. As an example PLA2 induces a transition to either micelle or a hexagonal phase due to the formation of lysolipids, whereas MMP will reduce headgroup size and induce a transition to an inverted micelle or the inverted hexagonal phase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.